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All infants experience a decrease in their haemoglobin 
concentration after birth, with the risk of anaemia 
being inversely related to gestational maturity 
and birth weight.[1] A decrease in haemoglobin is 
particularly prevalent in infants with a birth weight 
of less than 1 500 g, over half of whom develop anaemia.[2] Three 
basic mechanisms are responsible for the development of anaemia of 
prematurity, namely inadequate red blood cell production, shortened 
neonatal red blood cell lifespan, and iatrogenic blood loss (repeated 
blood sampling). [3] Babies with anaemia of prematurity often receive 
multiple blood transfusions (BTFs), with the risks of transmission of 
infections and iron overload.
Recent evidence has shown that accepting a lower haemoglobin 
threshold in premature infants before transfusing, i.e. adopting a 
restrictive BTF policy, resulted in no statistically significant difference in 
mortality or morbidity compared with infants receiving BTF at a higher, 
more liberal threshold.[4] Maintaining higher haemoglobin levels results 
in more infants receiving transfusions, but confers little benefit.[4]
The nursery at Groote Schuur Hospital (GSH), Cape Town, South 
Africa, did not have a formal BTF policy in place before 2010, and 
transfusion thresholds were often left to the discretion of individual 
clinicians. After adoption of a restrictive policy (Fig. 1), we conducted 
a study to determine whether it would reduce the number of BTFs.
Methods
The GSH nursery is a 75-bed tertiary unit that admits in excess of 
2 000 infants per year, over 500 of whom have a birth weight of less 
than 1 500 g.
Data were retrospectively collected on all infants who received red 
blood cell transfusions in the GSH nursery over a 6-month period in 
2011 after adoption of a restrictive BTF policy. Data were collected 
from the blood bank and the patients’ medical records and included 
gestational age, number of BTFs per infant, timing of BTF, clinical 
status and policy adherence. BTF figures for a similar 6-month period 
in 2008 before the restrictive policy were obtained for comparison. 
Data were analysed with Stata software version 12 (Statacorp, 
College Station, Tex., USA). Proportions were compared using the 
chi-square test. Statistical significance was set at p<0.05.
Ethical approval for the study was obtained from the University 
of Cape Town Faculty of Health Sciences Human Research Ethics 
Committee.
Results
The restrictive protocol was adhered to in 100% of cases in which 
infants received BTFs during the study period. After introduction of 
the restrictive policy, 42 (3.8%) of a total of 1 097 infants admitted 
received a total of 64 BTFs. Of the transfusions 70% were to babies 
with a birth weight of <1 500 g, with most transfusions (39%) being 
performed between 14 and 28 days after birth. Apart from one baby 
who developed necrotising enterocolitis after transfusion, no adverse 
events were recorded.
In comparison, 102 (10.9%) of a total of 940 infants admitted 
during a period of the same length before introduction of the 
restrictive policy received a total of 121 BTFs (Fig. 2). 
Comparison between total BTFs administered in 2008 and in 
2011 showed a highly statistically significant difference (p<0.001). 
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Background. Blood transfusions (BTFs) are not without risk and pose a significant financial burden on resource-limited services. In line 
with current international evidence, the nursery at Groote Schuur Hospital (GSH), Cape Town, South Africa, introduced a restrictive BTF 
protocol to minimise transfusions and manage costs. 
Objective. To determine whether adopting a restrictive BTF policy results in fewer transfusions. 
Methods. Data were retrospectively collected on all infants who received BTFs in the GSH nursery over a 6-month period following 
adoption of a restrictive BTF policy in 2010. BTF figures for a similar time period before the restrictive policy, during 2008, were obtained 
for comparison. 
Results. After introduction of the restrictive BTF policy, 42 of 1 097 infants admitted (3.8%) received a total of 64 BTFs. In comparison, 
102 of a total of 940 infants (10.9%) admitted during a period of the same length before introduction of the restrictive BTF policy received 
a total of 121 transfusions. Comparison between the number of BTFs administered before and after the restrictive policy showed a highly 
statistically significant difference (p<0.001). The total cost of the blood products used in the two 6-month periods was R91 870 v. R48 640, 
based on current prices. 
Conclusions. By adopting a restrictive policy, we were able to halve the number of BTFs, reduce risks associated with transfusions, and 
achieve significant cost benefits. Following evidence-based guidelines results in high standards of care, while also making the most effective 
use of resources.
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The cost of the blood products used in the 6 months of 2011 was 
R48 640 compared with R91 870 in 2008, based on current prices 
(Table 1).
Discussion
Before introduction of the restrictive BTF policy in the GSH nursery 
the unit did not have a standardised restrictive protocol to inform 
BTF decisions, which were left to the discretion of the individual 
attending doctors. These decisions were often made on an empiric 
basis, and variations in practice existed between individuals. 
In a recent Cochrane review, four trials that enrolled a total of 614 
infants compared low (restrictive) with high (liberal) haemoglobin 
thresholds. There were no statistically significant differences in the 
combined outcomes of death or serious morbidity at first hospital 
discharge.[5]
This review, coupled with our drive to adopt cost-effective 
evidence-based guidelines in our unit, resulted in the introduction of 
a restrictive BTF policy. The adoption of this protocol was consensus 
driven and had unanimous ‘buy in’ from all senior clinicians in the 
unit. The ‘buy-in’ was evidenced by the fact that the new protocol 
achieved 100% compliance during the entire study period.
Evidence-based medicine has been described as ‘the conscientious, 
explicit and judicious use of current best evidence in making 
decisions about the care of individual patients’.[6] Implementation of 
evidence-based protocols facilitates translation of clinical trials into 
day-to-day practice, with maintenance of the highest quality and 
safety of care. Furthermore, resources are allocated cost-effectively.
During the two time periods studied, while the number of admissions 
remained similar, the number of BTFs administered was almost halved. 
What was more marked was that the number of infants receiving BTFs 
was reduced from 102 to 42, representing an almost 60% reduction. 
This resulted in marked cost savings and preservation of scarce blood 
products, while also decreasing patient exposure to potentially harmful 
side-effects.
Conclusions
We have demonstrated that it is possible to achieve 100% compliance 
with the commitment of the entire healthcare team, while 
standardising neonatal care. We were able to halve the number of 
BTFs and achieve significant cost benefits. Following evidence-based 
guidelines ensures high standards of care while also making the most 
effective use of resources.
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Table 1. Cost of blood transfusion products in two 6-month 
periods
Total cost 
Before protocol implementation R91 870
After protocol implementation R48 640
Cost per admission 
Before protocol implementation R97.73












Fig. 2. Comparison of number of blood transfusions and infants tranfsused 
before and after implementation of the protocol.
<28 days≥28 days
Fio2 ≥30% Fio2 <30%
Hb <12 g/dl Hb <11 g/dl Hb <10 g/dl Hb <10 g/dl Hb <8 g/dl Hb <8 g/dl Hb <7 g/dl
CPAPAssisted ventilation Breathing spontaneously
<28 days ≥28 days Fio2 ≥21% Well in air
Fig. 1. The Groote Schuur Hospital blood transfusion protocol – guidelines for red blood cell transfusion thresholds for preterm neonates (CPAP = continuous 
positive airway pressure; FiO2 = fraction of inspired oxygen; Hb = haemoglobin concentration).
